Cytokine-Like 1 is a novel proangiogenic factor secreted by and mediating functions of endothelial progenitor cells

Rationale:Endothelial colony forming cells (ECFCs) or late blood outgrowth endothelial cells can be isolated from human cord or peripheral blood, display properties of endothelial progenitors, home into ischemic tissues and support neovascularization in ischemic disease models.Objective:To assess th...

Full description

Saved in:
Bibliographic Details
Main Authors: Schneller, Doris (Author) , Kapel, Stephanie (Author) , Besemfelder, Eva (Author) , Augustin, Hellmut (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: Circulation research
Year: 2019, Volume: 124, Issue: 2, Pages: 243-255
ISSN:1524-4571
DOI:10.1161/CIRCRESAHA.118.313645
Online Access:Verlag, Volltext: https://doi.org/10.1161/CIRCRESAHA.118.313645
Verlag, Volltext: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313645
Get full text
Author Notes:Schneller Doris, Hofer-Warbinek Renate, Sturtzel Caterina, Lipnik Karoline, Gencelli Burcu, Seltenhammer Monika, Wen Mingjie, Testori Julia, Bilban Martin, Borowski Andreas, Windwarder Markus, Kapel Stephanie S., Besemfelder Eva, Cejka Petra, Habertheuer Andreas, Schlechta Bernhard, Majdic Otto, Altmann Friedrich, Kocher Alfred, Augustin Hellmut G., Luttmann Werner, Hofer Erhard
Description
Summary:Rationale:Endothelial colony forming cells (ECFCs) or late blood outgrowth endothelial cells can be isolated from human cord or peripheral blood, display properties of endothelial progenitors, home into ischemic tissues and support neovascularization in ischemic disease models.Objective:To assess the functions of CYTL1 (cytokine-like 1), a factor we found preferentially produced by ECFCs, in regard of vessel formation.Methods and Results:We show by transcriptomic analysis that ECFCs are distinguished from endothelial cells of the vessel wall by production of high amounts of CYTL1. Modulation of expression demonstrates that the factor confers increased angiogenic sprouting capabilities to ECFCs and can also trigger sprouting of mature endothelial cells. The data further display that CYTL1 can be induced by hypoxia and that it functions largely independent of VEGF-A (vascular endothelial growth factor-A). By recombinant production of CYTL1 we confirm that the peptide is indeed a strong proangiogenic factor and induces sprouting in cellular assays and functional vessel formation in animal models comparable to VEGF-A. Mass spectroscopy corroborates that CYTL1 is specifically O-glycosylated on 2 neighboring threonines in the C-terminal part and this modification is important for its proangiogenic bioactivity. Further analyses show that the factor does not upregulate proinflammatory genes and strongly induces several metallothionein genes encoding anti-inflammatory and antiapoptotic proteins.Conclusions:We conclude that CYTL1 can mediate proangiogenic functions ascribed to endothelial progenitors such as ECFCs in vivo and may be a candidate to support vessel formation and tissue regeneration in ischemic pathologies.
Item Description:Originally published: October 26, 2018
Gesehen am 14.08.2019
Physical Description:Online Resource
ISSN:1524-4571
DOI:10.1161/CIRCRESAHA.118.313645